0001638599-15-000269.txt : 20151020 0001638599-15-000269.hdr.sgml : 20151020 20151020121238 ACCESSION NUMBER: 0001638599-15-000269 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151008 FILED AS OF DATE: 20151020 DATE AS OF CHANGE: 20151020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5600 BLAZER PARKWAY STREET 2: SUITE 200 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 5600 BLAZER PARKWAY STREET 2: SUITE 200 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDBERG MICHAEL M CENTRAL INDEX KEY: 0000905011 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 151165886 MAIL ADDRESS: STREET 1: C/O MONTAUR CAPITAL PARTNERS STREET 2: 152 WEST 57TH STREET, 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 4 1 doc4_3502.xml PRIMARY DOCUMENT X0306 4 2015-10-08 0 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0000905011 GOLDBERG MICHAEL M C/O MONTAUR CAPITAL PARTNERS 152 W. 57TH STREET, 4TH FLOOR NEW YORK NY 10019 1 0 0 0 Common Stock 2015-10-08 4 A 0 13247 2.26 A 331572 D Acquired from the Issuer in lieu of cash compensation for board service during 2Q and 3Q 2015. /s/William J. Kelly, attorney in fact 2015-10-20